SearcharxivSearch

arXiv · 2305.13343

A new sulfur bioconversion process development for energy- and space-efficient secondary wastewater treatment

Abstract

Harvesting organic matter from wastewater is widely applied to maximize energy recovery; however, it limits the applicability of secondary treatment for acceptable effluent discharge into surface water bodies. To turn this bottleneck issue into an opportunity, this study developed oxygen-induced thiosulfatE production duRing sulfATe reductiOn (EARTO) to provide an efficient electron donor for wastewater treatment. Typical pretreated wastewater was synthesized with chemical oxygen demand of 110 mg/L, sulfate of 50 mg S/L, and varying dissolved oxygen (DO) and was fed into a moving-bed biofilm reactor (MBBR). The MBBR was operated continuously with a short hydraulic retention time of 40 min for 349 days. The formation rate of thiosulfate reached 0.12-0.18 g S/(m2.d) with a high produced thiosulfate-S/TdS-S ratio of 38-73% when influent DO was 2.7-3.6 mg/L. The sludge yield was 0.23-0.29 gVSS/gCOD, much lower than it was in conventional activated sludge processes. Then, batch tests and metabolism analysis were conducted to confirm the oxygen effect on thiosulfate formation, characterize the roles of sulfate and microbial activities, and explore the mechanism of oxygen-induced thiosulfate formation in ERATO. Results examined that oxygen supply promoted the thiosulfate-Sproduced/TdS-Sproduced ratio from 4% to 24-26%, demonstrated that sulfate and microbial activities were critical for thiosulfate production, and indicated that oxygen induces thiosulfate formation through two pathways: 1) direct sulfide oxidation, and 2) indirect sulfide oxidation, sulfide is first oxidized to S0 (dominant) which then reacts with sulfite derived from oxygen-regulated biological sulfate reduction. The proposed compact ERATO process, featuring high thiosulfate production and low sludge production, supports space- and energy-efficient secondary wastewater treatment.

Explore related subjects

Keep this discovery

BibTeXRIS

Chu-Kuan Jiang, Yang-Fan Deng, Hongxiao Guo, Guang-Hao Chen, Di Wu. 2023-05-22. A new sulfur bioconversion process development for energy- and space-efficient secondary wastewater treatment. https://arxiv.org/abs/2305.13343

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

MarkerScout: A Disease-Agnostic Machine Learning Framework for Biomarker Prediction from Multi-Scale Mechanistic Models

We demonstrate the framework on three infectious diseases derived from a companion mechanistic immune-simulation platform: SARS-CoV-2, Influenza A Virus, and Plasmodium falciparum. Each disease was evaluated across hospitalization and intensive care unit cohorts, yielding six cohorts in total. Best-pipeline cross-validated macro F1 ranged from 0.82 for IAV-HOSP to 0.99 for COV-ICU, and the framework produced tiered, direction-aware biomarker lists for each disease and phase. Interleukin-18 (IL-18) reached the strongest tier in both SARS-CoV-2 phases with consistent direction. When benchmarked against three separate, independently collected clinical ICU datasets, MarkerScout's top-ranked features outperformed 94.4% of randomly selected feature sets of equivalent size for SARS-CoV-2, with a weaker but directionally consistent advantage for Influenza A Virus (66.7%) and Plasmodium falciparum (60.7%).

q-bio.OT

Enhancing Clinical Decision Support and Differential Diagnosis with Knowledge Graphs, and Retrieval Augmented Generation in Generative AI

Diagnostic error carries a burden, while unconstrained large language models (LLMs) remain vulnerable to hallucination and weak integration of quantitative laboratory dynamics. We developed a decision-support pipeline combining disease-specific biomarker correlation graphs, ordinary differential equations (ODEs), deep sequence classification, and retrieval-augmented generation (RAG). For 103 disease classes from a full blood count (FBC) repository, biomarker networks were used as coupling matrices to generate 30 trajectories per disease (3,090 total). A one-dimensional convolutional neural network (CNN) and long short-term memory (LSTM) network classified disease trajectories and six dynamical clusters. A constrained GPT-4o-mini RAG layer used a 19-pattern BMJ Best Practice/NICE corpus to generate differential diagnoses evaluated for diagnostic suitability, evidential grounding, and clinical plausibility. Across five random-seed runs, disease-level accuracy was $0.940 \pm 0.006$ for the CNN (95\% CI 0.933--0.948) and $0.852 \pm 0.019$ for the LSTM (95\% CI 0.828--0.875); the CNN advantage was 8.87 percentage points (95\% CI 6.47--11.27; $t(4)=10.26$, $p=5.1\times10^{-4}$; Hedges' $g=3.67$). Among 100 sampled RAG cases, 96 parsed successfully; evidence was cited in 97.9\%, the true diagnosis was mentioned in 71.9\%, and the composite score was 3.82/5 with a 47.9\% strict pass rate. The central finding was a decoupling between grounding and diagnostic correctness: classifier-correct versus classifier-wrong outputs differed in diagnostic suitability but not evidential grounding. Post-hoc analysis confirmed a 1.02-point diagnostic-score difference (Mann--Whitney $p=0.0024$; Hedges' $g=0.72$), whereas grounding differed by only $-0.02$ points ($p=0.839$; $g=-0.04$).

q-bio.OT

Expanding the Human Ancestry Ontology to include under-represented populations and ethnicities for broader utility in annotations

Successful discovery, integration and reuse of data relies on the availability of rich, well-structured and machine-readable metadata to describe every aspect of the data, from sample sources to collection processes to experimental protocols. The use of standardised terminologies to express concepts in a harmonised fashion lies at the core of high-quality data annotation, increasing the FAIRness of the data, facilitating data integration and promoting reproducibility. Here, we describe the Human Ancestry Ontology (HANCESTRO), originally developed to improve standardised reporting of genetic ancestry genomic resources such as the NHGRI-EBI GWAS Catalog and the Human Cell Atlas through high-level population descriptors, and more recently expanded to include diverse and previously under-represented populations in genomics and genetics research. HANCESTRO provides a framework for population descriptors that includes both ancestry based on the analysis of genetic information and self-reported ethnicity, which is based on social and cultural factors that don't necessarily align with genetic populations. By enabling the accurate and interoperable representation of population-related data, it promotes inclusive, representative and reproducible science.

q-bio.OT